PAVAN K. YADAV

About

I am a Postdoctoral Researcher at Stanford University, California, United States of America (CA, USA). I am passionate about using my skills and research knowledge to impact the world positively. I believe that my research has the potential to help us address some of the world's most pressing challenges in such a way as to treat breast and metastatic cancer at a worldwide level. I am excited to continue my research and contribute to developing novel technologies and novel drug delivery carrier systems to help us create a more sustainable future.

Employment

• Stanford University POSTDOCTORAL RESEARCHER
  2023 - Present
• Central Drug Research Institute Project Associate-I
  2023 - 2023

Education

• Central Drug Research Institute Doctor of Philosophy
  2018 - 2023
• Mahatma Jyotiba Phule Rohilkhand University M. PHARM (PHARMACEUTICS)
  2014 - 2018
• Mahatma Jyotiba Phule Rohilkhand University B. PHARM (Batchelor of Pharmacy)
  2010 - 2014

Projects & Funding

Projects & funding information is unavailable.

Publications (44)

• Nano-Arbortristoside-A: A targeted approach to enhance therapeutic efficacy in the treatment of leishmaniasis
  Next Nanotechnology 2026 DOI: 10.1016/j.nxnano.2026.100448
  +Save
• Development and Validation of RP–HPLC With Diode‐Array Detection–Based Method for Simultaneous Estimation of Berberine and Bromocriptine: Application in Formulation Development and Pharmacokinetic Studies in Parkinson's Disease
  SEPARATION SCIENCE PLUS 2026 DOI: 10.1002/sscp.70292
  +Save
• Metallic nanoparticles for photodynamic cancer therapy
  Nanophototherapy 2025 DOI: 10.1016/b978-0-443-13937-6.00024-x
  +Save
• Neuronal Membrane-Coated Mesoporous Ceria Nanoparticles for Blood−Brain Barrier Crossing and Mitigation of Neurodegeneration
  ACS Applied Nano Materials 2025 DOI: 10.1021/acsanm.5c00545
  +Save
• Nanotechnology Assisted Drug Delivery Strategies for Chemotherapy: Recent Advances and Future Prospects
  ACS Applied Bio Materials 2025 DOI: 10.1021/acsabm.5c00046
  +Save
• LC-MS/MS method for co-estimation of doxorubicin and piperine: formulation development and pharmacokinetic studies
  Bioanalysis 2025 DOI: 10.1080/17576180.2025.2548198
  +Save
• Highly sensitive validated RP-HPLC–DAD method for simultaneous quantification of doxorubicin and docetaxel: augmenting industrial application
  Accreditation and Quality Assurance 2025 DOI: 10.1007/s00769-025-01645-x
  +Save
• Engineered Nanoliposomes to Mitigate Osteolytic Bone Lesions in Breast Cancer
  ACS Applied Materials and Interfaces 2025 DOI: 10.1021/acsami.5c13155
  +Save
• Development of HPLC Method for Simultaneous Quantification of Doxorubicin and Baicalein Encapsulated in Unilamellar Liposomes
  Separation Science Plus 2025 DOI: 10.1002/sscp.70047
  +Save
• Designing pegylated dextran sheathed doxorubicin loaded iron nanoparticles against premenopausal breast cancer
  International Journal of Biological Macromolecules 2025 DOI: 10.1016/j.ijbiomac.2025.141874
  +Save